Elanco CEO granted 115 deferred stock units at $24.50

Q: What insider transaction did ELAN report for CEO Jeffrey Simmons?

Elanco reported that CEO Jeffrey N. Simmons acquired 115.3849 Deferred Stock Units on September 4, 2026, as a grant or award, increasing his directly held Deferred Stock Units to 25,245.5086.

Q: When will the Elanco (ELAN) Deferred Stock Units granted to the CEO settle?

The Deferred Stock Units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year in accordance with Elanco’s Executive Deferral and Stock Match Plan.

Elanco’s CEO received an additional deferred stock unit award tied to future settlement in stock or cash.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc (ELAN) reported that President and CEO Jeffrey N. Simmons received a grant of 115.3849 Deferred Stock Units on September 4, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan. Following this award, Simmons holds 25,245.5086 Deferred Stock Units directly.

Insider Trade Summary

Grant/Award: 115.3849 shares

Grant/Award 1 txn

Insider Simmons Jeffrey N

Role PRESIDENT, CEO AND DIRECTOR

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units ^{F1, F2}	115.3849	$24.50	$3K

Holdings After Transaction: Deferred Stock Units — 25,245.5086 contracts (Direct)

Footnotes (2)

F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred Stock Units granted: 115.3849 units Grant price per Deferred Stock Unit: $24.50 per unit Deferred Stock Units held after transaction: 25,245.5086 units

3 metrics

Deferred Stock Units granted 115.3849 units Grant to CEO Jeffrey N. Simmons on September 4, 2026

Grant price per Deferred Stock Unit $24.50 per unit Price associated with the September 4, 2026 award

Deferred Stock Units held after transaction 25,245.5086 units CEO’s direct Deferred Stock Unit holdings following the grant

Key Terms

Deferred Stock Units, cash equivalent, Executive Deferral and Stock Match Plan, termination of employment

4 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

cash equivalent financial

"right to receive one share of Company common stock or the cash equivalent"

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan"

termination of employment financial

"settle in cash or shares ... following termination of employment"

FAQ

What insider transaction did ELAN report for CEO Jeffrey Simmons?

Elanco reported that CEO Jeffrey N. Simmons acquired 115.3849 Deferred Stock Units on September 4, 2026, as a grant or award, increasing his directly held Deferred Stock Units to 25,245.5086.

What does each Deferred Stock Unit represent at Elanco (ELAN)?

Each Elanco Deferred Stock Unit represents the right to receive one share of company common stock or the cash equivalent, according to the filing’s footnote description.

When will the Elanco (ELAN) Deferred Stock Units granted to the CEO settle?

The Deferred Stock Units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year in accordance with Elanco’s Executive Deferral and Stock Match Plan.

How many Deferred Stock Units does the Elanco (ELAN) CEO hold after this Form 4 transaction?

After the September 4, 2026 grant, CEO Jeffrey N. Simmons directly holds 25,245.5086 Deferred Stock Units, as reported in the Form 4.

What price per unit is associated with the Elanco (ELAN) Deferred Stock Unit grant?

The Deferred Stock Unit grant to the Elanco CEO is reported at $24.50 per unit for the 115.3849 units awarded on September 4, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/09/2026 - 05:10 PM Accepted by SEC EDGAR 09/09/2026 - 05:09 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simmons Jeffrey N

(Last)

(First)

(Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS

INDIANA

46221

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	PRESIDENT, CEO AND DIRECTOR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Units	⁽¹⁾	09/04/2026		A		115.3849		⁽²⁾	⁽²⁾	Common Stock	115.3849	$24.5	25,245.5086	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Elanco CEO granted 115 deferred stock units at $24.50

Rhea-AI Filing Summary

Positive

Negative